A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
Clinical Trial Grant
Awarded By
Schrodinger, Inc.
Start Date
March 1, 2024
End Date
March 14, 2029
Awarded By
Schrodinger, Inc.
Start Date
March 1, 2024
End Date
March 14, 2029